Comparative analysis of predicted HLA binding of immunoglobulin idiotype sequences indicates T cell-mediated immunosurveillance in follicular lymphoma

Blood

Volumn 116, Issue 10, 2010, Pages 1734-1736

  Strothmeyer, Anna Maria ^a   Papaioannou, Dimitrios ^a   Dühren von Minden, Marcus ^a   Navarrete, Marcelo ^a   Zirlik, Katja ^a   Heining Mikesch, Kristina ^a   Veelken, Hendrik ^a  

^a UNIVERSITY OF FREIBURG   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

EPITOPE; HLA A ANTIGEN; HLA ANTIGEN; HLA B ANTIGEN; IMMUNOGLOBULIN IDIOTYPE; PROTEIN BINDING;

ADULT; AGED; ALGORITHM; ALLELE; COMPARATIVE STUDY; CYTOLOGY; FEMALE; FOLLICULAR LYMPHOMA; GENETICS; HUMAN; IMMUNOLOGICAL MONITORING; IMMUNOLOGY; MALE; METABOLISM; MIDDLE AGED; STATISTICS AND NUMERICAL DATA; T LYMPHOCYTE;

ADULT; AGED; ALGORITHMS; ALLELES; EPITOPES, T-LYMPHOCYTE; FEMALE; HLA ANTIGENS; HLA-A ANTIGENS; HLA-B ANTIGENS; HUMANS; IMMUNOGLOBULIN IDIOTYPES; LYMPHOMA, FOLLICULAR; MALE; MIDDLE AGED; MONITORING, IMMUNOLOGIC; PROTEIN BINDING; T-LYMPHOCYTES;

EID: 77956608707     PISSN: 00064971     EISSN: 15280020     Source Type: Journal    
DOI: 10.1182/blood-2010-02-270199     Document Type: Article

References (25)

1. Kwak LW, Campbell MJ, Czerwinski DK, Hart S, Miller RA, Levy R. Induction of immune responses in patients with B-cell lymphoma against the surface-immunoglobulin idiotype expressed by their tumors. N Engl J Med. 1992;327(17):1209-1215.
2. Bendandi M, Gocke CD, Kobrin CB, et al. Complete molecular remissions induced by patient-specific vaccination plus granulocyte-monocyte colony-stimulating factor against lymphoma. Nat Med. 1999;5(10):1171-1177. (Pubitemid 29474422)
3. Hsu FJ, Benike C, Fagnoni F, et al. Vaccination of patients with B-cell lymphoma using autologous antigen-pulsed dendritic cells. Nat Med. 1996;2(1):52-58.
4. Ai WZ, Tibshirani R, Taidi B, Czerwinski D, Levy R. Anti-idiotype antibody response after vaccination correlates with better overall survival in follicular lymphoma. Blood. 2009;113(23):5743-5746.
5. Levy R, Robertson M, Leonard J, Vose J, Denney D. Results of a phase 3 trial evaluating safety and efficacy of specific immunotherapy, recombinant idiotype (ID) conjugated to KLH (ID-KLH) with GM-CSF, compared to non-specific immunotherapy, KLH with GM-CSF, in patients with follicular non-Hodgkin's lymphoma (FNHL). Ann Oncol. 2008;19[suppl 4]:iv101.
6. Inoges S, Rodriguez-Calvillo M, Zabalegui N, et al. Clinical benefit associated with idiotypic vaccination in patients with follicular lymphoma. J Natl Cancer Inst. 2006;98(18):1292-1301. (Pubitemid 44530725)
7. Osterroth F, Garbe A, Fisch P, Veelken H. Stimulation of cytotoxic T cells against idiotype immunoglobulin of malignant lymphoma with proteinpulsed or idiotype-transduced dendritic cells. Blood. 2000;95(4):1342-1349.
8. Bertinetti C, Zirlik K, Heining-Mikesch K, et al. Phase I trial of a novel intradermal idiotype vaccine in patients with advanced B-cell lymphoma: specific immune responses despite profound immunosuppression. Cancer Res. 2006;66(8):4496-4502.
9. Navarrete MA, Heining-Mikesch K, Bertinetti-Lapatki C, Duehren-von Minden M, Hafkemeyer A, Veelken H. Vaccination with recombinant idiotype Fab fragments induces specific cellular immunity and clinical responses in untreated B-cell lymphoma patients. Blood. 2008;112(11):Abstract 235.
10. Bogen B, Ruffini P. Review: to what extent are T cells tolerant to immunoglobulin variable regions? Scand J Immunol. 2009;70(6):526-530.
11. Lauritzsen GF, Weiss S, Dembic Z, Bogen B. Naive idiotype-specific CD4+ T cells and immunosurveillance of B-cell tumors. Proc Natl Acad Sci U S A. 1994;91(12):5700-5704. (Pubitemid 24174396)
12. Bertinetti C, Simon F, Zirlik K, et al. Cloning of idiotype immunoglobulin genes in B cell lymphomas by anchored PCR and production of individual recombinant idiotype vaccines in Escherichia coli. Eur J Haematol. 2006;77(5):395-402.
13. Bahler DW, Campbell MJ, Hart S, Miller RA, Levy S, Levy R. Ig VH gene expression among human follicular lymphomas. Blood. 1991;78(6):1561-1568.
14. Mueller CR. Populationsgenetische Parameter der Gewebemerkmale der deutschen Bevölkerung und ihre Anwendung bei der Suche nach nicht-verwandten Blutstammzellspendern. In: Transfusion Medicine. Ulm, Sweden: Ulm University; 2000.
15. Middleton D, Menchaca L, Rood H, Komerofsky R. New allele frequency database: http://www.allelefrequencies.net. Tissue Antigens. 2003;61(5):403-407.
16. Chen W, Khilko S, Fecondo J, Margulies DH, McCluskey J. Determinant selection of major histocompatibility complex class I-restricted antigenic peptides is explained by class I-peptide affinity and is strongly influenced by nondominant anchor residues. J Exp Med. 1994;180(4):1471-1483. (Pubitemid 24983527)
17. Gricks CS, Rawlings E, Foroni L, Madrigal JA, Amlot PL. Somatically mutated regions of immunoglobulin on human B-cell lymphomas code for peptides that bind to autologous major histocompatibility complex class I, providing a potential target for cytotoxic T cells. Cancer Res. 2001;61(13):5145-5152. (Pubitemid 32681547)
18. Trojan A, Schultze JL, Witzens M, et al. Immunoglobulin framework-derived peptides function as cytotoxic T-cell epitopes commonly expressed in B-cell malignancies. Nat Med. 2000;6(6):667-672.
19. Cleary ML, Meeker TC, Levy S, et al. Clustering of extensive somatic mutations in the variable region of an immunoglobulin heavy chain gene from a human B cell lymphoma. Cell. 1986;44(1):97-106. (Pubitemid 16036717)
20. Ottensmeier CH, Thompsett AR, Zhu D, Wilkins BS, Sweetenham JW, Stevenson FK. Analysis of VH genes in follicular and diffuse lymphoma shows ongoing somatic mutation and multiple isotype transcripts in early disease with changes during disease progression. Blood. 1998;91(11):4292-4299.
21. Dolken G, Illerhaus G, Hirt C, Mertelsmann R. BCL-2/JH rearrangements in circulating B cells of healthy blood donors and patients with nonmalignant diseases. J Clin Oncol. 1996;14(4):1333-1344. (Pubitemid 126424611)
22. Summers KE, Goff LK, Wilson AG, Gupta RK, Lister TA, Fitzgibbon J. Frequency of the Bcl-2/IgH rearrangement in normal individuals: implications for the monitoring of disease in patients with follicular lymphoma. J Clin Oncol. 2001;19(2):420-424. (Pubitemid 32112854)
23. Warncke M, Buchner M, Thaller G, et al. Control of the specificity of T cell-mediated anti-idiotype immunity by natural regulatory T cells. Cancer Immunol Immunother. In press.
24. Ai WZ, Hou JZ, Zeiser R, Czerwinski D, Negrin RS, Levy R. Follicular lymphoma B cells induce the conversion of conventional CD4+ T cells to T-regulatory cells. Int J Cancer. 2009;124(1):239-244.
25. Yang ZZ, Novak AJ, Ziesmer SC, Witzig TE, Ansell SM. CD70+ non-Hodgkin lymphoma B cells induce Foxp3 expression and regulatory function in intratumoral CD4+CD25 T cells. Blood. 2007;110(7):2537-2544.